Day: November 2, 2021

Diversity of Investigative Site Staff Highly Associated with the Diversity of Patients Enrolled in Clinical Trials, According to Tufts Center for the Study of Drug Development

Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum

– Mr. Johnson brings broad commercial expertise with over 30 years of leadership spanning dermatology marketing, sales, sales management, digital...

error: Content is protected !!